VNPEPS
Encyclopedia · Nov 2, 2026

Retatrutide: research, regimens, price

Everything published about Retatrutide: mechanism, research areas, results, regimens, risks, comparisons — plus the dated Vietnam price and ordering rules.

Order from VietPeptideAll prices

FormatPrice (index Nov 2, 2026)Delivery
20 mgfrom 2 200 000 ₫Da Nang ~30 min · Vietnam 1–2 days

Compound dossier

What it is

Retatrutide combines GIP, GLP-1 and glucagon receptor activity in one molecule. This triple mechanism connects appetite control with glucose regulation and energy metabolism.

Status and action

An investigational triple-receptor agonist in clinical development for obesity and related metabolic conditions.

In short

A prominent next-generation metabolic peptide with a triple mechanism and substantial phase 2 weight-loss results.

Research results

In the phase 2 obesity trial, the 12 mg group achieved average weight reduction of 24.2% at 48 weeks, compared with 2.1% for placebo. Exploratory measures also showed improvements in blood pressure, lipids and glucose-related markers.

Research regimens

Phase 2 research schedule: Subcutaneous administration once weekly. Target-dose groups: 1, 4, 8 or 12 mg weekly. Higher-dose groups began at 2 or 4 mg, depending on the arm, with protocol-defined escalation. Duration: 48 weeks. These are separate clinical-trial groups, not one dose ladder. Phase 3 schedules start at 2 mg and use their own escalation steps.

Risks and limits

Nausea, diarrhoea and vomiting were the most frequent effects, often during escalation. Dose-dependent heart-rate increases were also observed; longer-term follow-up continues.

Comparison

Retatrutide adds glucagon-receptor activity to GIP and GLP-1 signalling. That third pathway makes it a distinct metabolic research approach; separate trials should not be treated as a direct comparison.

FAQ

How much does Retatrutide cost in Vietnam?

from 2 200 000 ₫ for 20 mg (index Nov 2, 2026); final total confirmed in writing before payment.

Is this a medicine?

No: research material, not a prescription drug; no medical claims.

Transparency: research data from published sources; regimens are research context, not medical advice. Price — public VietPeptide index. Full RU dossier: Retatrutide (RU)